{"entity":{"type":"insider","cik":"0001532475","url":"/insider/0001532475","json_url":"/insider/0001532475.json","name":"Goldberg Mark Alan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":30,"n_filings":22,"first":"2012-11-09","last":"2022-03-07","span_basis":"filed_date"},"name_variants":[{"name":"Goldberg Mark Alan","source":"filing","n_filings":22,"first_seen":"2012-11-09","last_seen":"2022-03-07"}],"transactions":[{"id":6505547,"accession":"0001415889-22-002653","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-002653","line_url":"/filing/0001415889-22-002653#line-1","is_derivative":false,"issuer_cik":"0001532475","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001532475","owner_cik":"0001532475","owner_name":"Goldberg Mark Alan","owner_display_name":"Goldberg Mark Alan","owner_url":"/insider/0001532475","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":59.98,"price_display":"59.98","price_state":"stated","total_value":299900.0,"total_display":"299,900.00","total_whole":"299,900","shares_owned_after":10812.0,"shares_owned_after_display":"10,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-03","filed_date":"2022-03-07","scope":"insider"},{"id":2089018,"accession":"0001179110-20-012241","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-012241","line_url":"/filing/0001179110-20-012241#line-2","is_derivative":false,"issuer_cik":"0001532475","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001532475","owner_cik":"0001532475","owner_name":"Goldberg Mark Alan","owner_display_name":"Goldberg Mark Alan","owner_url":"/insider/0001532475","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5455.0,"shares_display":"5,455","price_per_share":125.0,"price_display":"125.00","price_state":"stated","total_value":681875.0,"total_display":"681,875.00","total_whole":"681,875","shares_owned_after":3562.0,"shares_owned_after_display":"3,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-24","filed_date":"2020-12-28","scope":"insider"},{"id":2065160,"accession":"0001179110-20-012178","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-012178","line_url":"/filing/0001179110-20-012178#line-2","is_derivative":false,"issuer_cik":"0001532475","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001532475","owner_cik":"0001532475","owner_name":"Goldberg Mark Alan","owner_display_name":"Goldberg Mark Alan","owner_url":"/insider/0001532475","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5454.0,"shares_display":"5,454","price_per_share":120.0,"price_display":"120.00","price_state":"stated","total_value":654480.0,"total_display":"654,480.00","total_whole":"654,480","shares_owned_after":3562.0,"shares_owned_after_display":"3,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider"},{"id":3293948,"accession":"0001179110-20-011906","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-011906","line_url":"/filing/0001179110-20-011906#line-2","is_derivative":false,"issuer_cik":"0001532475","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001532475","owner_cik":"0001532475","owner_name":"Goldberg Mark Alan","owner_display_name":"Goldberg Mark Alan","owner_url":"/insider/0001532475","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5455.0,"shares_display":"5,455","price_per_share":115.0,"price_display":"115.00","price_state":"stated","total_value":627325.0,"total_display":"627,325.00","total_whole":"627,325","shares_owned_after":3562.0,"shares_owned_after_display":"3,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-11","filed_date":"2020-12-15","scope":"insider"},{"id":2816698,"accession":"0001179110-20-011608","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-011608","line_url":"/filing/0001179110-20-011608#line-2","is_derivative":false,"issuer_cik":"0001532475","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001532475","owner_cik":"0001532475","owner_name":"Goldberg Mark Alan","owner_display_name":"Goldberg Mark Alan","owner_url":"/insider/0001532475","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5454.0,"shares_display":"5,454","price_per_share":110.0,"price_display":"110.00","price_state":"stated","total_value":599940.0,"total_display":"599,940.00","total_whole":"599,940","shares_owned_after":3562.0,"shares_owned_after_display":"3,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-01","filed_date":"2020-12-03","scope":"insider"},{"id":3013213,"accession":"0001179110-20-010626","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-010626","line_url":"/filing/0001179110-20-010626#line-2","is_derivative":false,"issuer_cik":"0001532475","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001532475","owner_cik":"0001532475","owner_name":"Goldberg Mark Alan","owner_display_name":"Goldberg Mark Alan","owner_url":"/insider/0001532475","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5455.0,"shares_display":"5,455","price_per_share":105.0,"price_display":"105.00","price_state":"stated","total_value":572775.0,"total_display":"572,775.00","total_whole":"572,775","shares_owned_after":3562.0,"shares_owned_after_display":"3,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-19","filed_date":"2020-10-21","scope":"insider"},{"id":2816598,"accession":"0001179110-20-010368","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-010368","line_url":"/filing/0001179110-20-010368#line-2","is_derivative":false,"issuer_cik":"0001532475","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001532475","owner_cik":"0001532475","owner_name":"Goldberg Mark Alan","owner_display_name":"Goldberg Mark Alan","owner_url":"/insider/0001532475","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5454.0,"shares_display":"5,454","price_per_share":100.0,"price_display":"100.00","price_state":"stated","total_value":545400.0,"total_display":"545,400.00","total_whole":"545,400","shares_owned_after":3562.0,"shares_owned_after_display":"3,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-07","filed_date":"2020-10-09","scope":"insider"},{"id":6010912,"accession":"0001179110-18-014193","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-18-014193","line_url":"/filing/0001179110-18-014193#line-1","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":"0001532475","owner_name":"Goldberg Mark Alan","owner_display_name":"Goldberg Mark Alan","owner_url":"/insider/0001532475","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.1897,"price_display":"3.19","price_state":"stated","total_value":31897.0,"total_display":"31,897.00","total_whole":"31,897","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-19","filed_date":"2018-12-20","scope":"insider"},{"id":6579369,"accession":"0001179110-18-012629","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-18-012629","line_url":"/filing/0001179110-18-012629#line-1","is_derivative":false,"issuer_cik":"0000855654","issuer_name":"IMMUNOGEN INC","issuer_ticker":"IMGN","issuer_name_source":null,"issuer_url":"/issuer/0000855654","owner_cik":"0001532475","owner_name":"Goldberg Mark Alan","owner_display_name":"Goldberg Mark Alan","owner_url":"/insider/0001532475","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":5.76,"price_display":"5.76","price_state":"stated","total_value":172800.0,"total_display":"172,800.00","total_whole":"172,800","shares_owned_after":53800.0,"shares_owned_after_display":"53,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-06","filed_date":"2018-11-07","scope":"insider"},{"id":2352654,"accession":"0001179110-16-032974","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-16-032974","line_url":"/filing/0001179110-16-032974#line-1","is_derivative":false,"issuer_cik":"0000855654","issuer_name":"IMMUNOGEN INC","issuer_ticker":"IMGN","issuer_name_source":null,"issuer_url":"/issuer/0000855654","owner_cik":"0001532475","owner_name":"Goldberg Mark Alan","owner_display_name":"Goldberg Mark Alan","owner_url":"/insider/0001532475","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.8,"price_display":"1.80","price_state":"stated","total_value":36000.0,"total_display":"36,000.00","total_whole":"36,000","shares_owned_after":23800.0,"shares_owned_after_display":"23,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-15","filed_date":"2016-12-15","scope":"insider"},{"id":2053249,"accession":"0001209191-16-106323","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-106323","line_url":"/filing/0001209191-16-106323#line-1","is_derivative":false,"issuer_cik":"0001253689","issuer_name":"GLYCOMIMETICS INC","issuer_ticker":"GLYC","issuer_name_source":null,"issuer_url":"/issuer/0001253689","owner_cik":"0001532475","owner_name":"Goldberg Mark Alan","owner_display_name":"Goldberg Mark Alan","owner_url":"/insider/0001532475","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10397.0,"shares_display":"10,397","price_per_share":4.7735,"price_display":"4.77","price_state":"stated","total_value":49630.0795,"total_display":"49,630.08","total_whole":"49,630","shares_owned_after":11497.0,"shares_owned_after_display":"11,497","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-04","filed_date":"2016-03-07","scope":"insider"},{"id":6180255,"accession":"0001246360-14-003903","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001246360-14-003903","line_url":"/filing/0001246360-14-003903#line-2","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001532475","owner_name":"Goldberg Mark Alan","owner_display_name":"Goldberg Mark Alan","owner_url":"/insider/0001532475","role":"Officer (EVP, Medical & Reg. Strategy)","role_mark":"O","role_mark_label":"Officer (EVP, Medical & Reg. Strategy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Medical & Reg. Strategy","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":790.0,"shares_display":"790","price_per_share":65.24,"price_display":"65.24","price_state":"stated","total_value":51539.6,"total_display":"51,539.60","total_whole":"51,540","shares_owned_after":562.0,"shares_owned_after_display":"562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-19","filed_date":"2014-09-19","scope":"insider"},{"id":6684134,"accession":"0001246360-14-003888","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001246360-14-003888","line_url":"/filing/0001246360-14-003888#line-4","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001532475","owner_name":"Goldberg Mark Alan","owner_display_name":"Goldberg Mark Alan","owner_url":"/insider/0001532475","role":"Officer (EVP, Medical & Reg. Strategy)","role_mark":"O","role_mark_label":"Officer (EVP, Medical & Reg. Strategy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Medical & Reg. Strategy","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4200.0,"shares_display":"4,200","price_per_share":65.06,"price_display":"65.06","price_state":"stated","total_value":273252.0,"total_display":"273,252.00","total_whole":"273,252","shares_owned_after":562.0,"shares_owned_after_display":"562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-17","filed_date":"2014-09-18","scope":"insider"},{"id":6684128,"accession":"0001246360-14-003888","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001246360-14-003888","line_url":"/filing/0001246360-14-003888#line-2","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001532475","owner_name":"Goldberg Mark Alan","owner_display_name":"Goldberg Mark Alan","owner_url":"/insider/0001532475","role":"Officer (EVP, Medical & Reg. Strategy)","role_mark":"O","role_mark_label":"Officer (EVP, Medical & Reg. Strategy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Medical & Reg. Strategy","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9379.0,"shares_display":"9,379","price_per_share":65.01,"price_display":"65.01","price_state":"stated","total_value":609728.79,"total_display":"609,728.79","total_whole":"609,729","shares_owned_after":562.0,"shares_owned_after_display":"562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-16","filed_date":"2014-09-18","scope":"insider"},{"id":6584756,"accession":"0001246360-14-002912","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001246360-14-002912","line_url":"/filing/0001246360-14-002912#line-4","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001532475","owner_name":"Goldberg Mark Alan","owner_display_name":"Goldberg Mark Alan","owner_url":"/insider/0001532475","role":"Officer (EVP, Medical & Reg. Strategy)","role_mark":"O","role_mark_label":"Officer (EVP, Medical & Reg. Strategy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Medical & Reg. Strategy","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21597.0,"shares_display":"21,597","price_per_share":80.0,"price_display":"80.00","price_state":"stated","total_value":1727760.0,"total_display":"1,727,760.00","total_whole":"1,727,760","shares_owned_after":459.0,"shares_owned_after_display":"459","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-11","filed_date":"2014-06-12","scope":"insider"},{"id":5029181,"accession":"0001246360-13-005178","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001246360-13-005178","line_url":"/filing/0001246360-13-005178","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001532475","owner_name":"Goldberg Mark Alan","owner_display_name":"Goldberg Mark Alan","owner_url":"/insider/0001532475","role":"Officer (SVP,Medical&Regulatory Affairs)","role_mark":"O","role_mark_label":"Officer (SVP,Medical&Regulatory Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP,Medical&Regulatory Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":60.52127,"price_display":"60.52","price_state":"stated","total_value":423648.89,"total_display":"423,648.89","total_whole":"423,649","shares_owned_after":680.0,"shares_owned_after_display":"680","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-03","filed_date":"2013-12-04","scope":"insider","n_lines":2},{"id":5457674,"accession":"0001246360-13-004828","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001246360-13-004828","line_url":"/filing/0001246360-13-004828","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001532475","owner_name":"Goldberg Mark Alan","owner_display_name":"Goldberg Mark Alan","owner_url":"/insider/0001532475","role":"Officer (SVP,Medical&Regulatory Affairs)","role_mark":"O","role_mark_label":"Officer (SVP,Medical&Regulatory Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP,Medical&Regulatory Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":49.964664285714285,"price_display":"49.96","price_state":"stated","total_value":349752.65,"total_display":"349,752.65","total_whole":"349,753","shares_owned_after":3572.0,"shares_owned_after_display":"3,572","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-01","filed_date":"2013-11-04","scope":"insider","n_lines":3},{"id":5029116,"accession":"0001246360-13-004613","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001246360-13-004613","line_url":"/filing/0001246360-13-004613","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001532475","owner_name":"Goldberg Mark Alan","owner_display_name":"Goldberg Mark Alan","owner_url":"/insider/0001532475","role":"Officer (SVP,Medical&Regulatory Affairs)","role_mark":"O","role_mark_label":"Officer (SVP,Medical&Regulatory Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP,Medical&Regulatory Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":64.31468571428572,"price_display":"64.31","price_state":"stated","total_value":450202.8,"total_display":"450,202.80","total_whole":"450,203","shares_owned_after":267.0,"shares_owned_after_display":"267","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-01","filed_date":"2013-10-03","scope":"insider","n_lines":2},{"id":4491299,"accession":"0001246360-13-002338","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001246360-13-002338","line_url":"/filing/0001246360-13-002338","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001532475","owner_name":"Goldberg Mark Alan","owner_display_name":"Goldberg Mark Alan","owner_url":"/insider/0001532475","role":"Officer (SVP,Medical&Regulatory Affairs)","role_mark":"O","role_mark_label":"Officer (SVP,Medical&Regulatory Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP,Medical&Regulatory Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4416.0,"shares_display":"4,416","price_per_share":54.309522192028986,"price_display":"54.31","price_state":"stated","total_value":239830.85,"total_display":"239,830.85","total_whole":"239,831","shares_owned_after":619.0,"shares_owned_after_display":"619","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-01","filed_date":"2013-04-03","scope":"insider","n_lines":2},{"id":4338148,"accession":"0001246360-13-001904","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001246360-13-001904","line_url":"/filing/0001246360-13-001904","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001532475","owner_name":"Goldberg Mark Alan","owner_display_name":"Goldberg Mark Alan","owner_url":"/insider/0001532475","role":"Officer (SVP, Product Development)","role_mark":"O","role_mark_label":"Officer (SVP, Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4417.0,"shares_display":"4,417","price_per_share":50.76230699569844,"price_display":"50.76","price_state":"stated","total_value":224217.11,"total_display":"224,217.11","total_whole":"224,217","shares_owned_after":1713.0,"shares_owned_after_display":"1,713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-01","filed_date":"2013-03-06","scope":"insider","n_lines":2},{"id":5421875,"accession":"0001246360-13-000855","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001246360-13-000855","line_url":"/filing/0001246360-13-000855","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001532475","owner_name":"Goldberg Mark Alan","owner_display_name":"Goldberg Mark Alan","owner_url":"/insider/0001532475","role":"Officer (SVP, Product Development)","role_mark":"O","role_mark_label":"Officer (SVP, Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4417.0,"shares_display":"4,417","price_per_share":47.74553090332805,"price_display":"47.75","price_state":"stated","total_value":210892.01,"total_display":"210,892.01","total_whole":"210,892","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-01","filed_date":"2013-02-05","scope":"insider","n_lines":2},{"id":4311809,"accession":"0001246360-13-000270","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001246360-13-000270","line_url":"/filing/0001246360-13-000270#line-2","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001532475","owner_name":"Goldberg Mark Alan","owner_display_name":"Goldberg Mark Alan","owner_url":"/insider/0001532475","role":"Officer (SVP, Product Development)","role_mark":"O","role_mark_label":"Officer (SVP, Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4417.0,"shares_display":"4,417","price_per_share":47.52,"price_display":"47.52","price_state":"stated","total_value":209895.84,"total_display":"209,895.84","total_whole":"209,896","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-02","filed_date":"2013-01-04","scope":"insider"},{"id":2848395,"accession":"0001179110-12-015853","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-12-015853","line_url":"/filing/0001179110-12-015853#line-1","is_derivative":false,"issuer_cik":"0000855654","issuer_name":"IMMUNOGEN INC","issuer_ticker":"IMGN","issuer_name_source":null,"issuer_url":"/issuer/0000855654","owner_cik":"0001532475","owner_name":"Goldberg Mark Alan","owner_display_name":"Goldberg Mark Alan","owner_url":"/insider/0001532475","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":11.268,"price_display":"11.27","price_state":"stated","total_value":33804.0,"total_display":"33,804.00","total_whole":"33,804","shares_owned_after":3800.0,"shares_owned_after_display":"3,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-08","filed_date":"2012-11-09","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":30,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":30},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001597264","name":"Blueprint Medicines Corp","url":"/issuer/0001597264","role":"Director","n_filings":7,"first_seen":"2020-10-09","last_seen":"2022-03-07"},{"type":"issuer","type_label":"ISSUER","cik":"0000861838","name":"IDERA PHARMACEUTICALS, INC.","url":"/issuer/0000861838","role":"Director","n_filings":1,"first_seen":"2018-12-20","last_seen":"2018-12-20"},{"type":"issuer","type_label":"ISSUER","cik":"0000855654","name":"IMMUNOGEN INC","url":"/issuer/0000855654","role":"Director","n_filings":3,"first_seen":"2012-11-09","last_seen":"2018-11-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001253689","name":"GLYCOMIMETICS INC","url":"/issuer/0001253689","role":"Director","n_filings":1,"first_seen":"2016-03-07","last_seen":"2016-03-07"},{"type":"issuer","type_label":"ISSUER","cik":"0000911326","name":"SYNAGEVA BIOPHARMA CORP","url":"/issuer/0000911326","role":"Officer (EVP, Medical & Reg. Strategy)","n_filings":10,"first_seen":"2013-01-04","last_seen":"2014-09-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001532475","retrieved_at":"2026-08-25T15:16:44+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}